GBIO Generation Bio Co

  1. Stocks
  2. Healthcare
  3. NASDAQ: GBIO

Price (delayed)

$1.13

Market cap

$74.67M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.97

Enterprise value

$55.33M

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent ...

Highlights
Generation Bio's EPS has increased by 16% YoY and by 4.8% from the previous quarter
The net income has grown by 8% YoY and by 2.4% from the previous quarter
The quick ratio has contracted by 49% YoY and by 25% from the previous quarter
The equity has decreased by 25% YoY and by 9% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://generationbio.com
Peers: OMGA

Key stats

What are the main financial stats of GBIO
Market
Shares outstanding
66.08M
Market cap
$74.67M
Enterprise value
$55.33M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.32
Price to sales (P/S)
24.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.28
Earnings
Revenue
$3.03M
EBIT
-$123.83M
EBITDA
-$118.55M
Free cash flow
-$54.27M
Per share
EPS
-$1.97
Free cash flow per share
-$0.82
Book value per share
$3.52
Revenue per share
$0.05
TBVPS
$5.79
Balance sheet
Total assets
$381.49M
Total liabilities
$149.58M
Debt
$79.71M
Equity
$231.91M
Working capital
$264.99M
Liquidity
Debt to equity
0.34
Current ratio
9.07
Quick ratio
9.06
Net debt/EBITDA
0.16
Margins
EBITDA margin
-3,917.6%
Gross margin
100%
Net margin
-4,092.2%
Operating margin
-4,455.7%
Efficiency
Return on assets
-31.1%
Return on equity
-47.3%
Return on invested capital
-36.2%
Return on capital employed
-35.5%
Return on sales
-4,092.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GBIO stock price

How has the Generation Bio stock price performed over time
Intraday
-2.59%
1 week
-1.74%
1 month
17.98%
1 year
-78.8%
YTD
-71.25%
QTD
-70.18%

Financial performance

How have Generation Bio's revenue and profit performed over time
Revenue
$3.03M
Gross profit
$3.03M
Operating income
-$134.83M
Net income
-$123.83M
Gross margin
100%
Net margin
-4,092.2%
Generation Bio's net margin has soared by 72% from the previous quarter
GBIO's operating margin has surged by 71% since the previous quarter
The net income has grown by 8% YoY and by 2.4% from the previous quarter

Growth

What is Generation Bio's growth rate over time

Valuation

What is Generation Bio stock price valuation
P/E
N/A
P/B
0.32
P/S
24.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.28
Generation Bio's EPS has increased by 16% YoY and by 4.8% from the previous quarter
The P/B is 71% below the last 4 quarters average of 1.1
The equity has decreased by 25% YoY and by 9% QoQ

Efficiency

How efficient is Generation Bio business performance
Generation Bio's ROS has soared by 72% from the previous quarter
Generation Bio's ROIC has increased by 35% YoY and by 2.4% from the previous quarter
Generation Bio's ROE has decreased by 20% YoY and by 4.9% from the previous quarter

Dividends

What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GBIO.

Financial health

How did Generation Bio financials performed over time
Generation Bio's total assets is 155% higher than its total liabilities
GBIO's total liabilities has surged by 59% year-on-year
The current ratio is down by 49% year-on-year and by 25% since the previous quarter
Generation Bio's debt is 66% less than its equity
Generation Bio's debt to equity has increased by 26% YoY and by 6% QoQ
The equity has decreased by 25% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.